Actually, in recent years, several studies have found that KIAA0101 is overexpressed in various cancers, such as breast cancer [22], glioma [23], renal cancer [24], pancreatic cancer [25], esophageal cancer [26], lung small-cell cancer [27], colorectal cancer [28], and HCC [29, 30], and is related to a poor outcome. This evidence concerns the gene PCLAF and glioma.